| Multilayer control of the EMT master regulators H Zheng, Y Kang Oncogene 33 (14), 1755-1763, 2014 | 371 | 2014 |
| PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis H Zheng, M Shen, YL Zha, W Li, Y Wei, MA Blanco, G Ren, T Zhou, ... Cancer cell 26 (3), 358-373, 2014 | 225 | 2014 |
| Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis M Esposito, N Mondal, TM Greco, Y Wei, C Spadazzi, SC Lin, H Zheng, ... Nature cell biology 21 (5), 627-639, 2019 | 203 | 2019 |
| The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation D Zhao, HQ Zheng, Z Zhou, C Chen Cancer research 70 (11), 4728-4738, 2010 | 161 | 2010 |
| Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin/FAK and EGFR signaling M Shen, YZ Jiang, Y Wei, B Ell, X Sheng, M Esposito, J Kang, X Hang, ... Cancer cell 35 (1), 64-80. e7, 2019 | 159 | 2019 |
| Therapeutic antibody targeting tumor-and osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy H Zheng, Y Bae, S Kasimir-Bauer, R Tang, J Chen, G Ren, M Yuan, ... Cancer cell 32 (6), 731-747. e6, 2017 | 148 | 2017 |
| Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1 HQ Zheng, Z Zhou, J Huang, L Chaudhury, JT Dong, C Chen Oncogene 28 (42), 3702-3713, 2009 | 105 | 2009 |
| KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization R Liu, HQ Zheng, Z Zhou, JT Dong, C Chen Journal of Biological Chemistry 284 (25), 16791-16798, 2009 | 88 | 2009 |
| Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2 W Li, M Shen, YZ Jiang, R Zhang, H Zheng, Y Wei, ZM Shao, Y Kang Genes & development 34 (19-20), 1310-1315, 2020 | 58 | 2020 |
| ASB13 inhibits breast cancer metastasis through promoting SNAI2 degradation and relieving its transcriptional repression of YAP H Fan, X Wang, W Li, M Shen, Y Wei, H Zheng, Y Kang Genes & Development 34 (19-20), 1359-1372, 2020 | 36 | 2020 |
| Tumor–Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications H Zheng, W Li, Y Kang Cold Spring Harbor symposia on quantitative biology 81, 151-161, 2016 | 24 | 2016 |
| Tumor-derived Jagged1 promotes cancer progression through immune evasion J Meng, Y Jiang, S Zhao, Y Tao, T Zhang, X Wang, Y Zhang, K Sun, ... Cell Reports 38 (10), 2022 | 19 | 2022 |
| Cradle of evil: Osteogenic niche for early bone metastasis H Zheng, Y Kang Cancer cell 27 (2), 153-155, 2015 | 10 | 2015 |
| Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer H Fan, Z Xu, K Yao, B Zheng, Y Zhang, X Wang, T Zhang, X Li, H Hu, ... Cancer Research 84 (3), 449-467, 2024 | 1 | 2024 |
| Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer X Li, Y Zhang, T Zhang, L Zhao, CG Lin, H Hu, H Zheng Cancer Gene Therapy 31 (1), 69-81, 2024 | | 2024 |
| Lymphotoxin-β Promotes Bone Colonization and Osteolytic Outgrowth of Indolent Bone Metastatic cells of Breast Cancer X Wang, T Zhang, B Zheng, Y Lu, Y Liang, G Xu, L Zhao, Y Tao, Q Song, ... bioRxiv, 2023.08. 15.553179, 2023 | | 2023 |
| Targeting Metastatic Disease: Challenges and New Opportunities H Hu, Z Hu, H Zheng The Systemic Effects of Advanced Cancer: A Textbook on Cancer-Associated …, 2022 | | 2022 |
| Methods of treating or preventing breast cancer metastases using antibodies to jagged1 and chemotherapeutic agents Y Kang, H Zheng | | 2019 |
| Gain of function of Jagged1 stimulates osteoclastogenesis leading to low bone volume. Y Bae, H Zheng, Y Chen, T Bertin, Y Kang, B Lee JOURNAL OF BONE AND MINERAL RESEARCH 29, S45-S45, 2014 | | 2014 |
Yibin KangWarner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University在 princeton.edu 的电子邮件经过验证
